美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Acrivon Therapeutics, Inc.

1.34

+0.01000.75%

盘后：1.340.00000.00%19:41 EDT

成交量：6.68万

成交额：8.96万

市值：4,215.06万

市盈率：-0.60

高：1.37

开：1.33

低：1.32

收：1.33

52周最高：10.16

52周最低：1.05

股本：3,145.56万

流通股本：1,670.46万

量比：0.41

换手率：0.40%

股息：- -

股息率：- -

每股收益(TTM):-2.2435

每股收益(LYR):-2.3839

净资产收益率：-47.87%

总资产收益率：-30.32%

市净率：0.29

市盈率(LYR):-0.56

数据加载中...

总览公司新闻公告

Acrivon Therapeutics, Inc.2025财年第一财季实现净利润-19.68百万美元，同比减少19.35%

Acrivon Therapeutics, Inc.盘中异动股价大涨6.92%报1.23美元

Jones Trading：下调Acrivon Therapeutics评级

Acrivon Therapeutics, Inc.盘中异动急速拉升6.36%报1.17美元

奥本海默：维持Acrivon Therapeutics评级，由优于大市调整至优于大市评级, 目标价由10.00美元调整至9.00美元。

Acrivon Therapeutics, Inc.盘中异动早盘股价大涨5.60%

Acrivon Therapeutics, Inc.4月9日成交额为36.35万美元

Acrivon Therapeutics, Inc.4月7日成交额为24.45万美元

Acrivon Therapeutics, Inc.4月4日成交额为47.67万美元

Acrivon Therapeutics, Inc.4月2日成交额为50.25万美元

嗡嗡声--美国股票走势-Fractyl Health、Keurig Dr Pepper、PVH

BUZZ-美国股市走势--强生公司、加密货币公司、Nayax

BUZZ-Maxim 因取消卵巢和膀胱项目的优先级而削减 Acrivon PT

美国研究综述-美国国际集团、Corcept Therapeutics、陶氏化学

Acrivon Therapeutics, Inc.3月31日成交额为58.62万美元

美国研究综述-Braze、Home Bancshares、联合太平洋公司

Acrivon Therapeutics, Inc.2024财年实现净利润-80.56百万美元，同比减少33.40%

Acrivon Therapeutics, Inc.3月28日成交额为99.94万美元

Acrivon Therapeutics, Inc.3月26日成交额为603.45万美元

嗡嗡声--美国股票走势-OrganiGram, Phillips 66, SurgePays

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ACRV/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACRV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACRV\",,,,,undefined,":{"symbol":"ACRV","market":"US","secType":"STK","nameCN":"Acrivon Therapeutics, Inc.","latestPrice":1.34,"timestamp":1756497600000,"preClose":1.33,"halted":0,"volume":66758,"hourTrading":{"tag":"盘后","latestPrice":1.34,"preClose":1.34,"latestTime":"19:41 EDT","volume":850,"amount":1138.3868,"timestamp":1756510861508},"delay":0,"floatShares":16704630,"shares":31455645,"eps":-2.243506,"marketStatus":"劳工日休市","change":0.01,"latestTime":"08-29 16:00:00 EDT","open":1.33,"high":1.37,"low":1.32,"amount":89577.13277459999,"amplitude":0.037594,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.243506,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1756800000000},"marketStatusCode":7,"adr":0,"listingDate":1668488400000,"exchange":"NASDAQ","adjPreClose":1.33,"preHourTrading":{"tag":"盘前","latestPrice":1.389,"preClose":1.33,"latestTime":"08:00 EDT","volume":1,"amount":1.389,"timestamp":1756468800817},"postHourTrading":{"tag":"盘后","latestPrice":1.34,"preClose":1.34,"latestTime":"19:41 EDT","volume":850,"amount":1138.3868,"timestamp":1756510861508},"volumeRatio":0.4118957978573393},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACRV\",,,,,undefined,":{"symbol":"ACRV","floatShares":16704630,"roa":"-30.32%","roe":"-47.87%","lyrEps":-2.38389,"volumeRatio":0.4118957978573393,"shares":31455645,"dividePrice":0,"high":1.37,"amplitude":0.037594,"preClose":1.33,"low":1.32,"week52Low":1.05,"pbRate":"0.29","week52High":10.16,"institutionHeld":0,"latestPrice":1.34,"eps":-2.243506,"divideRate":0,"volume":66758,"delay":0,"ttmEps":-2.243506,"open":1.33,"prevYearClose":6.02,"prevWeekClose":1.34,"prevMonthClose":1.34,"prevQuarterClose":1.19,"fiveDayClose":1.36,"twentyDayClose":1.26,"sixtyDayClose":1.23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACRV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-13","symbol":"ACRV","fiscalQuarterEnding":"2025/06","expectedEps":-0.57,"name":null,"time":"盘后","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.55},{"market":"US","date":"2025-05-14","symbol":"ACRV","fiscalQuarterEnding":"2025/03","expectedEps":-0.57,"name":null,"time":"盘后","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-0.51},{"market":"US","date":"2025-03-27","symbol":"ACRV","fiscalQuarterEnding":"2024/12","expectedEps":-0.69,"name":null,"time":"盘后","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"post","actualEps":-0.6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACRV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACRV\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2222,"buy":0.6667,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1747454400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ACRV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ACRV","date":"2025-08-29","current":-0.486703,"percent":0.922741,"low":-18.228389,"twenty":-7.496042,"median":-3.352976,"eighty":-1.788312,"high":-0.393112,"avg":-4.688495,"sd":4.107844,"marketCap":41836007},"quantilePoints":[{"date":"2022-11-11","current":-11.86111,"twenty":-16.13111,"median":-16.13111,"eighty":-13.56911,"marketCap":235122787},{"date":"2022-11-18","current":-16.605358,"twenty":-17.148347,"median":-16.336664,"eighty":-13.56911,"marketCap":329168006},{"date":"2022-11-25","current":-13.1538,"twenty":-16.59273,"median":-14.65824,"eighty":-13.1538,"marketCap":260747787},{"date":"2022-12-02","current":-13.311646,"twenty":-16.459997,"median":-13.18537,"eighty":-13.1538,"marketCap":263876760},{"date":"2022-12-09","current":-13.1538,"twenty":-16.13111,"median":-13.18537,"eighty":-13.1538,"marketCap":260747787},{"date":"2022-12-16","current":-9.42062,"twenty":-15.609309,"median":-13.164324,"eighty":-13.1538,"marketCap":250409495},{"date":"2022-12-23","current":-9.15348,"twenty":-13.492642,"median":-13.1538,"eighty":-9.908718,"marketCap":243308642},{"date":"2022-12-30","current":-9.051338,"twenty":-13.374784,"median":-13.1538,"eighty":-9.15348,"marketCap":240593610},{"date":"2023-01-06","current":-9.114194,"twenty":-13.324274,"median":-13.1538,"eighty":-9.10948,"marketCap":242264399},{"date":"2023-01-13","current":-9.758474,"twenty":-13.286391,"median":-13.1538,"eighty":-9.096909,"marketCap":259389986},{"date":"2023-01-20","current":-11.102032,"twenty":-13.261136,"median":-11.86111,"eighty":-9.107908,"marketCap":295103100},{"date":"2023-01-27","current":-11.416314,"twenty":-13.210625,"median":-11.432028,"eighty":-9.118908,"marketCap":303457044},{"date":"2023-02-03","current":-14.967707,"twenty":-13.261136,"median":-11.549884,"eighty":-9.140908,"marketCap":397856621},{"date":"2023-02-10","current":-17.254113,"twenty":-13.707494,"median":-12.294777,"eighty":-9.280764,"marketCap":458631569},{"date":"2023-02-17","current":-16.963401,"twenty":-16.209458,"median":-13.1538,"eighty":-9.39862,"marketCap":450904170},{"date":"2023-02-24","current":-12.044879,"twenty":-16.13111,"median":-12.885585,"eighty":-9.423763,"marketCap":320164934},{"date":"2023-03-03","current":-16.499835,"twenty":-16.177918,"median":-13.1538,"eighty":-9.434763,"marketCap":438582102},{"date":"2023-03-10","current":-15.745556,"twenty":-16.430693,"median":-13.1538,"eighty":-9.447334,"marketCap":418532634},{"date":"2023-03-17","current":-15.714128,"twenty":-16.525265,"median":-13.1538,"eighty":-9.527476,"marketCap":417697240},{"date":"2023-03-24","current":-10.229897,"twenty":-16.430693,"median":-13.1538,"eighty":-9.461476,"marketCap":271920903},{"date":"2023-03-31","current":-8.928026,"twenty":-16.282979,"median":-13.1538,"eighty":-9.434763,"marketCap":278259784},{"date":"2023-04-06","current":-7.274688,"twenty":-16.215409,"median":-13.019693,"eighty":-9.37662,"marketCap":226730194},{"date":"2023-04-14","current":-6.723819,"twenty":-16.19352,"median":-12.044879,"eighty":-9.115765,"marketCap":209561261},{"date":"2023-04-21","current":-8.060143,"twenty":-16.13111,"median":-11.86111,"eighty":-9.056052,"marketCap":251210465},{"date":"2023-04-28","current":-8.650938,"twenty":-16.126284,"median":-11.549884,"eighty":-9.035624,"marketCap":269623798},{"date":"2023-05-05","current":-7.956584,"twenty":-16.088124,"median":-11.377028,"eighty":-8.91982,"marketCap":247982856},{"date":"2023-05-12","current":-8.118522,"twenty":-16.003268,"median":-11.21203,"eighty":-8.835959,"marketCap":297974095},{"date":"2023-05-19","current":-7.88554,"twenty":-15.962411,"median":-10.807392,"eighty":-8.673871,"marketCap":289422962},{"date":"2023-05-26","current":-7.467367,"twenty":-15.908983,"median":-10.229897,"eighty":-8.438641,"marketCap":274074775},{"date":"2023-06-02","current":-7.419576,"twenty":-15.745556,"median":-9.829187,"eighty":-8.257075,"marketCap":272320696},{"date":"2023-06-09","current":-7.353863,"twenty":-15.714128,"median":-9.671273,"eighty":-8.064756,"marketCap":269908838},{"date":"2023-06-16","current":-7.138803,"twenty":-14.967707,"median":-9.475619,"eighty":-7.88554,"marketCap":262015484},{"date":"2023-06-23","current":-7.694375,"twenty":-14.936279,"median":-9.444191,"eighty":-7.691985,"marketCap":282406648},{"date":"2023-06-30","current":-7.957226,"twenty":-14.607853,"median":-9.4246,"eighty":-7.737387,"marketCap":292054080},{"date":"2023-07-07","current":-6.962573,"twenty":-14.230714,"median":-9.36562,"eighty":-7.687206,"marketCap":255547320},{"date":"2023-07-14","current":-7.312046,"twenty":-13.800187,"median":-9.122051,"eighty":-7.479315,"marketCap":268374019},{"date":"2023-07-21","current":-7.795931,"twenty":-13.463178,"median":-9.09848,"eighty":-7.467367,"marketCap":286134065},{"date":"2023-07-28","current":-7.335941,"twenty":-13.349529,"median":-9.063123,"eighty":-7.467367,"marketCap":269251058},{"date":"2023-08-04","current":-7.049195,"twenty":-13.305332,"median":-9.04741,"eighty":-7.451835,"marketCap":258726587},{"date":"2023-08-11","current":-6.929717,"twenty":-13.273763,"median":-9.035624,"eighty":-7.414797,"marketCap":254341391},{"date":"2023-08-18","current":-5.439761,"twenty":-13.23588,"median":-8.933664,"eighty":-7.374175,"marketCap":243684992},{"date":"2023-08-25","current":-5.824092,"twenty":-13.18537,"median":-8.917768,"eighty":-7.335941,"marketCap":260901867},{"date":"2023-09-01","current":-5.774819,"twenty":-13.181161,"median":-8.846512,"eighty":-7.295319,"marketCap":258694575},{"date":"2023-09-08","current":-5.764965,"twenty":-13.164324,"median":-8.810263,"eighty":-7.252307,"marketCap":258253117},{"date":"2023-09-15","current":-5.415125,"twenty":-13.164324,"median":-8.657972,"eighty":-7.138803,"marketCap":242581346},{"date":"2023-09-22","current":-4.666172,"twenty":-13.15801,"median":-8.650938,"eighty":-7.070701,"marketCap":209030514},{"date":"2023-09-28","current":-4.848483,"twenty":-13.1538,"median":-8.470778,"eighty":-7.024104,"marketCap":217197493},{"date":"2023-10-06","current":-3.606798,"twenty":-13.1538,"median":-8.337045,"eighty":-6.962573,"marketCap":161573745},{"date":"2023-10-13","current":-3.074648,"twenty":-13.1538,"median":-8.233741,"eighty":-6.723819,"marketCap":137734995},{"date":"2023-10-20","current":-2.670607,"twenty":-13.1538,"median":-8.118522,"eighty":-6.217422,"marketCap":119635204},{"date":"2023-10-27","current":-2.498151,"twenty":-13.1538,"median":-8.106574,"eighty":-6.135872,"marketCap":111909684},{"date":"2023-11-03","current":-2.650898,"twenty":-13.1538,"median":-8.060143,"eighty":-5.913769,"marketCap":118752288},{"date":"2023-11-10","current":-2.023663,"twenty":-13.1538,"median":-7.990082,"eighty":-5.83986,"marketCap":101314684},{"date":"2023-11-17","current":-1.968296,"twenty":-13.1538,"median":-7.956584,"eighty":-5.774819,"marketCap":98542723},{"date":"2023-11-24","current":-1.70231,"twenty":-13.1538,"median":-7.867618,"eighty":-5.710764,"marketCap":85226138},{"date":"2023-12-01","current":-1.795405,"twenty":-12.885585,"median":-7.837749,"eighty":-5.538308,"marketCap":89886943},{"date":"2023-12-08","current":-2.38944,"twenty":-12.728444,"median":-7.795931,"eighty":-5.434834,"marketCap":119627314},{"date":"2023-12-15","current":-2.220982,"twenty":-12.181592,"median":-7.694375,"eighty":-5.139195,"marketCap":111193478},{"date":"2023-12-22","current":-2.158919,"twenty":-11.988308,"median":-7.676453,"eighty":-4.765704,"marketCap":108086275},{"date":"2023-12-29","current":-2.207683,"twenty":-11.903452,"median":-7.658532,"eighty":-4.607044,"marketCap":110527648},{"date":"2024-01-05","current":-2.061391,"twenty":-11.878047,"median":-7.57191,"eighty":-4.424734,"marketCap":103203527},{"date":"2024-01-12","current":-2.136753,"twenty":-11.86111,"median":-7.467367,"eighty":-3.380635,"marketCap":106976559},{"date":"2024-01-19","current":-1.928398,"twenty":-11.771191,"median":-7.467367,"eighty":-3.021433,"marketCap":96545235},{"date":"2024-01-26","current":-1.795405,"twenty":-11.601741,"median":-7.461393,"eighty":-2.812514,"marketCap":89886943},{"date":"2024-02-02","current":-1.711176,"twenty":-11.509027,"median":-7.449445,"eighty":-2.678491,"marketCap":85670025},{"date":"2024-02-09","current":-1.569317,"twenty":-11.435171,"median":-7.416589,"eighty":-2.525448,"marketCap":78567846},{"date":"2024-02-16","current":-1.773239,"twenty":-11.384886,"median":-7.389706,"eighty":-2.417812,"marketCap":88777228},{"date":"2024-02-23","current":-1.693444,"twenty":-11.315743,"median":-7.371785,"eighty":-2.305211,"marketCap":84782252},{"date":"2024-03-01","current":-2.154486,"twenty":-11.224602,"median":-7.341915,"eighty":-2.222755,"marketCap":107864332},{"date":"2024-03-08","current":-2.274179,"twenty":-11.19003,"median":-7.329968,"eighty":-2.220982,"marketCap":113856794},{"date":"2024-03-15","current":-2.247581,"twenty":-11.059604,"median":-7.297111,"eighty":-2.213003,"marketCap":112525136},{"date":"2024-03-22","current":-2.806151,"twenty":-10.856891,"median":-7.272415,"eighty":-2.217436,"marketCap":140489963},{"date":"2024-03-28","current":-2.376071,"twenty":-10.724892,"median":-7.222437,"eighty":-2.220982,"marketCap":143486194},{"date":"2024-04-05","current":-2.507803,"twenty":-10.284897,"median":-7.147764,"eighty":-2.220982,"marketCap":151441202},{"date":"2024-04-12","current":-3.482435,"twenty":-10.229897,"median":-7.085038,"eighty":-2.220982,"marketCap":210297274},{"date":"2024-04-19","current":-5.388706,"twenty":-10.049185,"median":-7.03426,"eighty":-2.229848,"marketCap":325413151},{"date":"2024-04-26","current":-4.330392,"twenty":-9.829187,"median":-6.98405,"eighty":-2.238715,"marketCap":261503737},{"date":"2024-05-03","current":-4.325468,"twenty":-9.758474,"median":-6.941664,"eighty":-2.247581,"marketCap":261206357},{"date":"2024-05-10","current":-4.161857,"twenty":-9.701929,"median":-6.723819,"eighty":-2.252014,"marketCap":251326211},{"date":"2024-05-17","current":-4.122189,"twenty":-9.640618,"median":-6.484687,"eighty":-2.274179,"marketCap":264306537},{"date":"2024-05-24","current":-3.905485,"twenty":-9.530619,"median":-6.182256,"eighty":-2.300778,"marketCap":250411918},{"date":"2024-05-31","current":-3.717675,"twenty":-9.486619,"median":-5.962057,"eighty":-2.304324,"marketCap":238369915},{"date":"2024-06-07","current":-3.49134,"twenty":-9.456762,"median":-5.903338,"eighty":-2.319397,"marketCap":223857757},{"date":"2024-06-14","current":-3.49134,"twenty":-9.445762,"median":-5.863511,"eighty":-2.33713,"marketCap":223857757},{"date":"2024-06-21","current":-3.183139,"twenty":-9.434763,"median":-5.824092,"eighty":-2.361913,"marketCap":204096520},{"date":"2024-06-28","current":-2.793072,"twenty":-9.426151,"median":-5.774819,"eighty":-2.384092,"marketCap":179086205},{"date":"2024-07-05","current":-3.404659,"twenty":-9.423008,"median":-5.767428,"eighty":-2.38944,"marketCap":218299909},{"date":"2024-07-12","current":-3.587653,"twenty":-9.39862,"median":-5.666418,"eighty":-2.403626,"marketCap":230033143},{"date":"2024-07-19","current":-3.529865,"twenty":-9.280764,"median":-5.543235,"eighty":-2.426576,"marketCap":226327911},{"date":"2024-07-26","current":-4.266659,"twenty":-9.140908,"median":-5.474253,"eighty":-2.441598,"marketCap":273569617},{"date":"2024-08-02","current":-3.63581,"twenty":-9.122051,"median":-5.42498,"eighty":-2.474845,"marketCap":233120836},{"date":"2024-08-09","current":-3.703229,"twenty":-9.118908,"median":-5.388706,"eighty":-2.497195,"marketCap":237443607},{"date":"2024-08-16","current":-3.411328,"twenty":-9.107908,"median":-5.155584,"eighty":-2.500122,"marketCap":235388438},{"date":"2024-08-23","current":-4.201319,"twenty":-9.095337,"median":-5.020597,"eighty":-2.503539,"marketCap":289899445},{"date":"2024-08-30","current":-4.259671,"twenty":-9.084337,"median":-4.902952,"eighty":-2.504417,"marketCap":293925826},{"date":"2024-09-06","current":-3.62678,"twenty":-9.070195,"median":-4.859549,"eighty":-2.505321,"marketCap":250255077},{"date":"2024-09-13","current":-3.999333,"twenty":-9.051338,"median":-4.841316,"eighty":-2.507803,"marketCap":275961972},{"date":"2024-09-20","current":-3.352976,"twenty":-9.049767,"median":-4.688345,"eighty":-2.511616,"marketCap":231362057},{"date":"2024-09-27","current":-3.21383,"twenty":-9.04191,"median":-4.607044,"eighty":-2.532949,"marketCap":221760687},{"date":"2024-10-04","current":-3.146501,"twenty":-9.035624,"median":-4.498696,"eighty":-2.562206,"marketCap":217114862},{"date":"2024-10-11","current":-3.272182,"twenty":-9.016796,"median":-4.434588,"eighty":-2.595712,"marketCap":225787068},{"date":"2024-10-18","current":-3.703086,"twenty":-8.941048,"median":-4.32793,"eighty":-2.65484,"marketCap":255520344},{"date":"2024-10-25","current":-3.572917,"twenty":-8.937048,"median":-4.281106,"eighty":-2.672533,"marketCap":246538417},{"date":"2024-11-01","current":-3.59536,"twenty":-8.928026,"median":-4.264137,"eighty":-2.682254,"marketCap":248087025},{"date":"2024-11-08","current":-3.846721,"twenty":-8.925974,"median":-4.246205,"eighty":-2.692288,"marketCap":265431436},{"date":"2024-11-15","current":-2.815239,"twenty":-8.917768,"median":-4.204595,"eighty":-2.703682,"marketCap":216708620},{"date":"2024-11-22","current":-2.649398,"twenty":-8.907034,"median":-4.16553,"eighty":-2.65484,"marketCap":203942738},{"date":"2024-11-29","current":-3.066021,"twenty":-8.864099,"median":-4.160922,"eighty":-2.670607,"marketCap":236013123},{"date":"2024-12-06","current":-2.596815,"twenty":-8.828924,"median":-4.126009,"eighty":-2.650898,"marketCap":199895020},{"date":"2024-12-13","current":-2.855687,"twenty":-8.814854,"median":-4.120525,"eighty":-2.670607,"marketCap":219822249},{"date":"2024-12-20","current":-2.714117,"twenty":-8.805671,"median":-4.068333,"eighty":-2.680238,"marketCap":208924546},{"date":"2024-12-27","current":-2.394571,"twenty":-8.751109,"median":-4.0331,"eighty":-2.645353,"marketCap":184326872},{"date":"2025-01-03","current":-2.677713,"twenty":-8.689771,"median":-4.012605,"eighty":-2.604905,"marketCap":206122279},{"date":"2025-01-10","current":-2.212551,"twenty":-8.655158,"median":-3.960865,"eighty":-2.587876,"marketCap":170315539},{"date":"2025-01-17","current":-2.337942,"twenty":-8.650938,"median":-3.900584,"eighty":-2.551877,"marketCap":179967790},{"date":"2025-01-24","current":-2.204461,"twenty":-8.625618,"median":-3.852513,"eighty":-2.521343,"marketCap":169692813},{"date":"2025-01-31","current":-2.455244,"twenty":-8.502914,"median":-3.835171,"eighty":-2.504323,"marketCap":188997316},{"date":"2025-02-07","current":-2.43502,"twenty":-8.401182,"median":-3.809173,"eighty":-2.50322,"marketCap":187440501},{"date":"2025-02-14","current":-2.192327,"twenty":-8.329184,"median":-3.763471,"eighty":-2.461772,"marketCap":168758724},{"date":"2025-02-21","current":-2.240865,"twenty":-8.297738,"median":-3.75246,"eighty":-2.43502,"marketCap":172495079},{"date":"2025-02-28","current":-2.147833,"twenty":-8.257075,"median":-3.717675,"eighty":-2.390526,"marketCap":165333731},{"date":"2025-03-07","current":-2.240865,"twenty":-8.210407,"median":-3.714869,"eighty":-2.366257,"marketCap":172495079},{"date":"2025-03-14","current":-2.200416,"twenty":-8.154365,"median":-3.703229,"eighty":-2.322944,"marketCap":169381450},{"date":"2025-03-21","current":-2.168057,"twenty":-8.118522,"median":-3.698597,"eighty":-2.300778,"marketCap":166890546},{"date":"2025-03-28","current":-0.871783,"twenty":-8.106574,"median":-3.680643,"eighty":-2.269179,"marketCap":70227315},{"date":"2025-04-04","current":-0.587675,"twenty":-8.064756,"median":-3.655072,"eighty":-2.252014,"marketCap":47340734},{"date":"2025-04-11","current":-0.630486,"twenty":-8.060143,"median":-3.640625,"eighty":-2.24491,"marketCap":50789397},{"date":"2025-04-17","current":-0.704431,"twenty":-8.039938,"median":-3.63581,"eighty":-2.240865,"marketCap":56746178},{"date":"2025-04-25","current":-0.638341,"twenty":-8.020549,"median":-3.631295,"eighty":-2.235426,"marketCap":51422173},{"date":"2025-05-02","current":-0.548817,"twenty":-7.973953,"median":-3.617803,"eighty":-2.223945,"marketCap":44210527},{"date":"2025-05-09","current":-0.451509,"twenty":-7.958421,"median":-3.612522,"eighty":-2.214841,"marketCap":36371781},{"date":"2025-05-16","current":-0.430551,"twenty":-7.956712,"median":-3.606138,"eighty":-2.211394,"marketCap":36058665},{"date":"2025-05-23","current":-0.430551,"twenty":-7.899749,"median":-3.596322,"eighty":-2.204461,"marketCap":36058665},{"date":"2025-05-30","current":-0.411832,"twenty":-7.874787,"median":-3.589262,"eighty":-2.194384,"marketCap":34490897},{"date":"2025-06-06","current":-0.46799,"twenty":-7.860449,"median":-3.572307,"eighty":-2.185046,"marketCap":39194201},{"date":"2025-06-13","current":-0.475478,"twenty":-7.85567,"median":-3.556351,"eighty":-2.168057,"marketCap":39821308},{"date":"2025-06-20","current":-0.464247,"twenty":-7.841333,"median":-3.540333,"eighty":-2.161322,"marketCap":38880647},{"date":"2025-06-27","current":-0.490454,"twenty":-7.815048,"median":-3.529865,"eighty":-2.150494,"marketCap":41075522},{"date":"2025-07-03","current":-0.482966,"twenty":-7.805489,"median":-3.520234,"eighty":-2.141361,"marketCap":40448415},{"date":"2025-07-11","current":-0.50543,"twenty":-7.789957,"median":-3.49134,"eighty":-2.109268,"marketCap":42329737},{"date":"2025-07-18","current":-0.494198,"twenty":-7.751725,"median":-3.478657,"eighty":-2.07907,"marketCap":41389076},{"date":"2025-07-25","current":-0.520405,"twenty":-7.691985,"median":-3.452815,"eighty":-2.037985,"marketCap":43583951},{"date":"2025-08-01","current":-0.479222,"twenty":-7.680037,"median":-3.411328,"eighty":-2.021493,"marketCap":40134862},{"date":"2025-08-08","current":-0.475478,"twenty":-7.66809,"median":-3.410401,"eighty":-1.970956,"marketCap":39821308},{"date":"2025-08-15","current":-0.508659,"twenty":-7.656142,"median":-3.404659,"eighty":-1.930615,"marketCap":43723346},{"date":"2025-08-22","current":-0.483043,"twenty":-7.616715,"median":-3.37891,"eighty":-1.884954,"marketCap":41521451},{"date":"2025-08-29","current":-0.486703,"twenty":-7.496042,"median":-3.352976,"eighty":-1.788312,"marketCap":41836007}],"updateTime":1756707278101},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACRV\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2537923194","title":"Acrivon Therapeutics, Inc.2025财年第一财季实现净利润-19.68百万美元，同比减少19.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537923194","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537923194?lang=zh_cn&edition=fundamental","pubTime":"2025-05-23 00:00","pubTimestamp":1747929643,"startTime":"0","endTime":"0","summary":"5月23日，Acrivon Therapeutics, Inc.公布财报，公告显示公司2025财年第一财季净利润为-19.68百万美元，同比减少19.35%；其中营业收入为0.00美元，每股基本收益为-0.51美元。机构评级：截至2025年5月23日，当前有7家机构对Acrivon Therapeutics, Inc.目标价做出预测，其中目标均价为10.71美元，其中最低目标价为6.00美元，最高目标价为19.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000246a6e91510&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000246a6e91510&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ACRV"],"gpt_icon":0},{"id":"2536068795","title":"Acrivon Therapeutics, Inc.盘中异动 股价大涨6.92%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536068795","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536068795?lang=zh_cn&edition=fundamental","pubTime":"2025-05-19 21:31","pubTimestamp":1747661507,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日21时31分，Acrivon Therapeutics, Inc.股票出现异动，股价大幅上涨6.92%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。该信息摘要如下：奥本海默：维持Acrivon Therapeutics评级，由优于大市调整至优于大市评级, 目标价由10.00美元调整至9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213147aa2c925f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213147aa2c925f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","LENZ","BK4007","ACRV"],"gpt_icon":0},{"id":"2536032378","title":"Jones Trading：下调Acrivon Therapeutics评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2536032378","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536032378?lang=zh_cn&edition=fundamental","pubTime":"2025-05-17 04:51","pubTimestamp":1747428684,"startTime":"0","endTime":"0","summary":"Jones Trading：下调Acrivon Therapeutics评级，由买入调整至持有评级。Acrivon Therapeutics公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。该公司的计划包括2期先导项目——ACR-368，称为prexasertib，是一种靶向肿瘤资产，以及针对DNA损伤反应和细胞周期调节通路中的关键节点的临床前阶段计划，包括蛋白激酶——WEE1，和紧密相关的蛋白丝氨酸/苏氨酸激酶——PKMYT1。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517045521a481515d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517045521a481515d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ACRV"],"gpt_icon":0},{"id":"2535631678","title":"Acrivon Therapeutics, Inc.盘中异动 急速拉升6.36%报1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535631678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535631678?lang=zh_cn&edition=fundamental","pubTime":"2025-05-16 21:43","pubTimestamp":1747403027,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时43分，Acrivon Therapeutics, Inc.股票出现异动，股价大幅拉升6.36%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。该信息摘要如下：奥本海默：维持Acrivon Therapeutics评级，由优于大市调整至优于大市评级, 目标价由10.00美元调整至9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516214348a6e1bc42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516214348a6e1bc42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4139","BK4007","ACRV"],"gpt_icon":0},{"id":"2535871440","title":"奥本海默：维持Acrivon Therapeutics评级，由优于大市调整至优于大市评级, 目标价由10.00美元调整至9.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535871440","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535871440?lang=zh_cn&edition=fundamental","pubTime":"2025-05-16 02:13","pubTimestamp":1747332785,"startTime":"0","endTime":"0","summary":"奥本海默：维持Acrivon Therapeutics(ACRV.US)评级，由优于大市调整至优于大市评级, 目标价由10.00美元调整至9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516021526975aec28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516021526975aec28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRV","LENZ"],"gpt_icon":0},{"id":"2534776912","title":"Acrivon Therapeutics, Inc.盘中异动 早盘股价大涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534776912","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534776912?lang=zh_cn&edition=fundamental","pubTime":"2025-05-12 21:32","pubTimestamp":1747056749,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时32分，Acrivon Therapeutics, Inc.股票出现波动，股价急速上涨5.60%。Acrivon Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Acrivon Therapeutics, Inc.公司简介：Acrivon Therapeutics Inc是一家临床阶段的生物制药公司，开发肿瘤药物，利用其基于蛋白质组学的患者响应器识别平台，将其匹配到预测肿瘤对每种特定药物敏感的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221322994f481cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221322994f481cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","ACRV","BK4007","LENZ"],"gpt_icon":0},{"id":"2526324092","title":"Acrivon Therapeutics, Inc.4月9日成交额为36.35万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526324092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526324092?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 09:15","pubTimestamp":1744247723,"startTime":"0","endTime":"0","summary":"美东时间2025年4月9日，Acrivon Therapeutics, Inc.成交额为36.35万美元，成交额较昨日减少11.11%，当日成交量为24.69万股。Acrivon Therapeutics, Inc.于2025年4月9日涨18.38%，报1.61美元，该股过去5个交易日跌7.47%，年初至今跌73.26%，过去60日跌70.78%。该公司的计划包括2期先导项目——ACR-368，称为prexasertib，是一种靶向肿瘤资产，以及针对DNA损伤反应和细胞周期调节通路中的关键节点的临床前阶段计划，包括蛋白激酶——WEE1，和紧密相关的蛋白丝氨酸/苏氨酸激酶——PKMYT1。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410091534a4545127&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410091534a4545127&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","ACRV","LENZ"],"gpt_icon":0},{"id":"2525025160","title":"Acrivon Therapeutics, Inc.4月7日成交额为24.45万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525025160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525025160?lang=zh_cn&edition=fundamental","pubTime":"2025-04-08 09:15","pubTimestamp":1744074922,"startTime":"0","endTime":"0","summary":"美东时间2025年4月7日，Acrivon Therapeutics, Inc.成交额为24.45万美元，成交额较昨日减少48.72%，当日成交量为16.97万股。Acrivon Therapeutics, Inc.于2025年4月7日跌7.95%，报1.39美元，该股过去5个交易日跌31.53%，年初至今跌76.91%，过去60日跌77.21%。该公司的计划包括2期先导项目——ACR-368，称为prexasertib，是一种靶向肿瘤资产，以及针对DNA损伤反应和细胞周期调节通路中的关键节点的临床前阶段计划，包括蛋白激酶——WEE1，和紧密相关的蛋白丝氨酸/苏氨酸激酶——PKMYT1。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408091532a4519543&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250408091532a4519543&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ACRV","BK4007"],"gpt_icon":0},{"id":"2525750333","title":"Acrivon Therapeutics, Inc.4月4日成交额为47.67万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2525750333","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525750333?lang=zh_cn&edition=fundamental","pubTime":"2025-04-05 09:15","pubTimestamp":1743815725,"startTime":"0","endTime":"0","summary":"美东时间2025年4月4日，Acrivon Therapeutics, Inc.成交额为47.67万美元，成交额较昨日增加67.52%，当日成交量为31.80万股。Acrivon Therapeutics, Inc.于2025年4月4日跌7.93%，报1.51美元，该股过去5个交易日跌32.59%，年初至今跌74.92%，过去60日跌76.03%。该公司的计划包括2期先导项目——ACR-368，称为prexasertib，是一种靶向肿瘤资产，以及针对DNA损伤反应和细胞周期调节通路中的关键节点的临床前阶段计划，包括蛋白激酶——WEE1，和紧密相关的蛋白丝氨酸/苏氨酸激酶——PKMYT1。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405091533a6b03421&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250405091533a6b03421&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACRV","LENZ"],"gpt_icon":0},{"id":"2524420037","title":"Acrivon Therapeutics, Inc.4月2日成交额为50.25万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524420037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524420037?lang=zh_cn&edition=fundamental","pubTime":"2025-04-03 09:15","pubTimestamp":1743642925,"startTime":"0","endTime":"0","summary":"美东时间2025年4月2日，Acrivon Therapeutics, Inc.成交额为50.25万美元，成交额较昨日减少49.96%，当日成交量为28.89万股。Acrivon Therapeutics, Inc.于2025年4月2日涨3.57%，报1.74美元，该股过去5个交易日跌33.33%，年初至今跌71.1%，过去60日跌73.72%。该公司的计划包括2期先导项目——ACR-368，称为prexasertib，是一种靶向肿瘤资产，以及针对DNA损伤反应和细胞周期调节通路中的关键节点的临床前阶段计划，包括蛋白激酶——WEE1，和紧密相关的蛋白丝氨酸/苏氨酸激酶——PKMYT1。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250403091536a44bf184&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250403091536a44bf184&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ACRV","BK4139"],"gpt_icon":0},{"id":"2524111911","title":"嗡嗡声--美国股票走势-Fractyl Health、Keurig Dr Pepper、PVH","url":"https://stock-news.laohu8.com/highlight/detail?id=2524111911","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524111911?lang=zh_cn&edition=fundamental","pubTime":"2025-04-01 21:22","pubTimestamp":1743513774,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nL3T3QF12F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FCF","LU0225283273.USD","LUV","LU0788108826.HKD","LU1548497426.USD","LU1221951129.SGD","LU2028103732.USD","BK4585","KDP","HUT","IE00BDGV0183.EUR","AZO","LU2430703095.HKD","LPLA","LU0289739699.SGD","LU0353189680.USD","LU1894683348.USD","GUTS","NMAX","PVH","LU1223082196.USD","EE","IE0034235303.USD","LU1032466523.USD","ACRV","PRGS","IE0002141913.USD","DAL","LU1934455863.HKD","SG9999002224.SGD","BK4017","IE00BVYPNV92.GBP","JNJ","LU1162221912.USD","NEM","UAL","LU1894683264.USD","VRTX","IE00BKVL7J92.USD","LU0345769631.USD","RIOT","BK4581","SYNX","EVS.SI","LU0640476718.USD"],"gpt_icon":1},{"id":"2524972561","title":"BUZZ-美国股市走势--强生公司、加密货币公司、Nayax","url":"https://stock-news.laohu8.com/highlight/detail?id=2524972561","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524972561?lang=zh_cn&edition=fundamental","pubTime":"2025-04-01 19:43","pubTimestamp":1743507812,"startTime":"0","endTime":"0","summary":"O  >:BUZZ - William Blair 将以色列金融科技公司 Nayax 的评级提升至 \"跑赢大盘\"  nL3N3QF0SK  ** Acrivon Therapeutics Inc < ACRV.O  >:BUZZ - Maxim下调Acrivon的PT，原因是其卵巢和膀胱项目的优先级被取消  nL6N3QF0JH  ** Progress Software Corp < PRGS.O  >:BUZZ - 业绩超预期，上调年度每股收益预期后取得进展 nL6N3QF0JQ (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nL3T3QF0Y2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU1032466523.USD","IE00B19Z3B42.SGD","BK4547","BK4588","LU1929549753.HKD","LU2456880835.USD","IE000M9KFDE8.USD","LU0300736062.USD","LU2112291526.USD","BK4600","LU0300736492.USD","LU0980610538.SGD","PRGS","RIOT","LU1023059063.AUD","ACRV","LU1732800096.USD","LU2505996681.GBP","BK4551","NMAX","EVS.SI","FCF","LU1066051225.USD","IE00BVYPNV92.GBP","LU1894683348.USD","LU2430703178.SGD","NEM","IE00B19Z3581.USD","IE00B42XCP33.USD","LU0477156953.USD","LU0882574055.USD","LPLA","LU0345780281.USD","LU1430594728.SGD","EE","LU1430597077.USD","LU1066051498.USD","LU1023059493.AUD","BK4561","LU0795875086.SGD","LU0788109121.HKD","IE0009355771.USD","LU0724618789.USD","HUT","IE00B3PB1722.GBP","JNJ"],"gpt_icon":1},{"id":"2524194594","title":"BUZZ-Maxim 因取消卵巢和膀胱项目的优先级而削减 Acrivon PT","url":"https://stock-news.laohu8.com/highlight/detail?id=2524194594","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524194594?lang=zh_cn&edition=fundamental","pubTime":"2025-04-01 19:01","pubTimestamp":1743505260,"startTime":"0","endTime":"0","summary":"BUZZ-Maxim 因取消卵巢和膀胱项目的优先级而削减 Acrivon PT4月1日 -   ** 马克西姆集团将药物开发商Acrivon Therapeutics ACRV.O的PT值从24美元下调至7美元 ** 理由是取消了卵巢癌和膀胱癌项目的优先权 ** 经纪公司称：\"管理层宣布，由于卵巢癌的治疗门槛较高，而招募膀胱癌OncoSignature阳性患者存在困难，公司将取消这些项目的优先权。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nL3T3QF0W4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACRV","BK4139"],"gpt_icon":0},{"id":"2524155981","title":"美国研究综述-美国国际集团、Corcept Therapeutics、陶氏化学","url":"https://stock-news.laohu8.com/highlight/detail?id=2524155981","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524155981?lang=zh_cn&edition=fundamental","pubTime":"2025-04-01 14:50","pubTimestamp":1743490258,"startTime":"0","endTime":"0","summary":"美国研究综述-美国国际集团、Corcept Therapeutics、陶氏化学路透社4月1日 - 华尔街证券分析师周二修改了对几家美国上市公司的评级和目标价，其中包括 AIG、Corcept Therapeutics 和陶氏。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nL3T3QF0L5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORT","IE0002270589.USD","HMST","AIRS","FLIC","DOW","LU0994945656.USD","LU0053671581.USD","PCVX","ACRV","LU0348723411.USD","SLG","LU1571399168.USD","HUMA","VNO","BK4532","LU2506952170.USD","LU0130103400.USD","LU1201861249.SGD","VRSN","CRIS","AIG","PRGS","LU1668664300.SGD","BK4097","BK4150","LU0426412945.USD","BK4017","BK4090","IE00B19Z3581.USD","LU0648001328.SGD","BK4211","LU0130517989.USD","LU0648000940.SGD","LU2065170008.USD","AVNT","LU0823417737.USD","LU2065171402.SGD","LU0234570918.USD","BLRX","BK4563","BK4566","BK4223","SSRM","BK4116","BK4196","LU0498741890.SGD","BYD","BK4585","BK4588"],"gpt_icon":0},{"id":"2524186707","title":"Acrivon Therapeutics, Inc.3月31日成交额为58.62万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2524186707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524186707?lang=zh_cn&edition=fundamental","pubTime":"2025-04-01 09:15","pubTimestamp":1743470127,"startTime":"0","endTime":"0","summary":"美东时间2025年3月31日，Acrivon Therapeutics, Inc.成交额为58.62万美元，成交额较昨日减少41.34%，当日成交量为27.57万股。Acrivon Therapeutics, Inc.于2025年3月31日跌9.38%，报2.03美元，该股过去5个交易日跌63.81%，年初至今跌66.28%，过去60日跌66.28%。该公司的计划包括2期先导项目——ACR-368，称为prexasertib，是一种靶向肿瘤资产，以及针对DNA损伤反应和细胞周期调节通路中的关键节点的临床前阶段计划，包括蛋白激酶——WEE1，和紧密相关的蛋白丝氨酸/苏氨酸激酶——PKMYT1。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250401091539a4493c4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250401091539a4493c4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ACRV"],"gpt_icon":0},{"id":"2523494689","title":"美国研究综述-Braze、Home Bancshares、联合太平洋公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2523494689","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523494689?lang=zh_cn&edition=fundamental","pubTime":"2025-03-31 20:40","pubTimestamp":1743424815,"startTime":"0","endTime":"0","summary":"美国研究综述-Braze、Home Bancshares、联合太平洋公司路透社3月31日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括 Braze、Home Bancshares 和 Union Pacific。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nL3T3QE0RC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACRV","BXMT","KPLT","BRZE","CSX","LU2357305700.SGD","INTU","BILL","CFR","CMA","FTNT","IBM","LU2286300806.USD","PTCT","GLPI","AVDX","FLG","DOCU","LU1629891620.HKD","LU2242649171.HKD","SDST","DT","GPN","DDOG","LU1043141123.HKD","IE00B19Z9Z06.USD","IE00B19Z8X17.USD","LU0310800965.SGD","HOMB","NSC","USAW.SI","BOKF","IIPR","CL","FRSH","ELF","REGN","LU2242650005.HKD","SG9999001424.SGD","UNP","LU0203347892.USD","LU2098885051.SGD","BKU","KMTS"],"gpt_icon":1},{"id":"2523643499","title":"Acrivon Therapeutics, Inc.2024财年实现净利润-80.56百万美元，同比减少33.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2523643499","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523643499?lang=zh_cn&edition=fundamental","pubTime":"2025-03-30 07:00","pubTimestamp":1743289250,"startTime":"0","endTime":"0","summary":"3月30日，Acrivon Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-80.56百万美元，同比减少33.40%；其中营业收入为0.00美元，每股基本收益为-2.38美元。机构评级：截至2025年3月30日，当前有6家机构对Acrivon Therapeutics, Inc.目标价做出预测，其中目标均价为15.67美元，其中最低目标价为10.00美元，最高目标价为22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250330070056a6a8d9cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250330070056a6a8d9cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ACRV"],"gpt_icon":0},{"id":"2523865631","title":"Acrivon Therapeutics, Inc.3月28日成交额为99.94万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2523865631","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523865631?lang=zh_cn&edition=fundamental","pubTime":"2025-03-29 09:15","pubTimestamp":1743210926,"startTime":"0","endTime":"0","summary":"美东时间2025年3月28日，Acrivon Therapeutics, Inc.成交额为99.94万美元，成交额较昨日减少29.16%，当日成交量为43.67万股。Acrivon Therapeutics, Inc.于2025年3月28日跌11.11%，报2.24美元，该股过去5个交易日跌58.21%，年初至今跌62.79%，过去60日跌58.6%。该公司的计划包括2期先导项目——ACR-368，称为prexasertib，是一种靶向肿瘤资产，以及针对DNA损伤反应和细胞周期调节通路中的关键节点的临床前阶段计划，包括蛋白激酶——WEE1，和紧密相关的蛋白丝氨酸/苏氨酸激酶——PKMYT1。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250329091532a6a8150b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250329091532a6a8150b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACRV","LENZ"],"gpt_icon":0},{"id":"2522163364","title":"Acrivon Therapeutics, Inc.3月26日成交额为603.45万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2522163364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522163364?lang=zh_cn&edition=fundamental","pubTime":"2025-03-27 09:15","pubTimestamp":1743038128,"startTime":"0","endTime":"0","summary":"美东时间2025年3月26日，Acrivon Therapeutics, Inc.成交额为603.45万美元，成交额较昨日增加2319.71%，当日成交量为187.75万股。Acrivon Therapeutics, Inc.于2025年3月26日跌51.58%，报2.61美元，该股过去5个交易日跌52.2%，年初至今跌56.64%，过去60日跌57.84%。该公司的计划包括2期先导项目——ACR-368，称为prexasertib，是一种靶向肿瘤资产，以及针对DNA损伤反应和细胞周期调节通路中的关键节点的临床前阶段计划，包括蛋白激酶——WEE1，和紧密相关的蛋白丝氨酸/苏氨酸激酶——PKMYT1。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250327091538a44340d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250327091538a44340d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ACRV"],"gpt_icon":0},{"id":"2522538100","title":"嗡嗡声--美国股票走势-OrganiGram, Phillips 66, SurgePays","url":"https://stock-news.laohu8.com/highlight/detail?id=2522538100","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522538100?lang=zh_cn&edition=fundamental","pubTime":"2025-03-26 23:45","pubTimestamp":1743003917,"startTime":"0","endTime":"0","summary":".N美国东部时间11:30，道琼斯工业平均指数.DJI上涨0.06%，报42,612.53点。标准普尔500指数.SPX下跌0.54%，报5745.76点；纳斯达克综合指数.IXIC下跌1.18%，报18057.35点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nL3S3Q91B9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B42XCP33.USD","RILY","SARO","VVX","PSX","VVPR","LU0477156953.USD","ANET","RIO.UK","SURG","BK4130","WVE","BK4585","FCX","RIO.AU","LU1941712264.USD","GWRS","IE0008368304.USD","WING","LU0320765059.SGD","BHP.AU","CHWY","BEDU","CTAS","IE00BLSP4239.USD","SF","PAYX","PVLA","SCCO","SPWH","DLTR","SG9999001176.USD","PTPI","GCTS","JKS","WOR","BK4076","BBIO","HUMA","LU0348723411.USD","AEP","MPWR","IE00B19Z3B42.SGD","ALNY","ACRV"],"gpt_icon":1}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}]}}